微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | -5.94% | 77.41% | 98.73% | 144/159 | 1.43% | 百利天恒 | 186.1% | 行业排名> |
| 2022-12-31 | -466.44% | -290.23% | -308.08% | 150/159 | -2.31% | 百利天恒 | 186.89% | 行业排名> |
| 2022-09-30 | -114.3% | -703.23% | -62.01% | 145/159 | 2.5% | 百利天恒 | 188.56% | 行业排名> |
| 2022-06-30 | -70.55% | -818.62% | -168.25% | 149/159 | 1.77% | 小方制药 | 41.8% | 行业排名> |
| 2022-03-31 | -26.3% | -2611.34% | 78% | 140/159 | 1.54% | 拓新药业 | 20.51% | 行业排名> |
| 2021-12-31 | -119.53% | -794.69% | -739.99% | 149/159 | -0.07% | 拓新药业 | 19.87% | 行业排名> |
| 2021-09-30 | -14.23% | -1012.18% | -85.29% | 131/159 | 4.73% | 拓新药业 | 19.91% | 行业排名> |
| 2021-06-30 | -7.68% | -1025.3% | -691.75% | 139/159 | 3.06% | 小方制药 | 55.57% | 行业排名> |
| 2021-03-31 | -0.97% | -330.95% | 92.74% | 120/159 | 2.5% | 福元医药 | 25.41% | 行业排名> |
| 2020-12-31 | -13.36% | -680.87% | -956.41% | 127/159 | 4.12% | 小方制药 | 34.81% | 行业排名> |
| 2020-09-30 | 1.56% | -83.7% | 87.95% | 100/159 | 3.9% | 退市金泰 | 10.74% | 行业排名> |
| 2020-06-30 | 0.83% | -87.23% | 97.62% | 108/159 | 4.34% | 人福医药 | 6.82% | 行业排名> |
| 2020-03-31 | 0.42% | -89.26% | -81.74% | 82/159 | 2.27% | 小方制药 | 71.99% | 行业排名> |
| 2019-12-31 | 2.3% | -86.16% | -75.97% | 109/159 | 3.3% | 汇宇制药 | 39.25% | 行业排名> |
| 2019-09-30 | 9.57% | -35.64% | 47.23% | 40/159 | 7.59% | 汇宇制药 | 28.14% | 行业排名> |
| 2019-06-30 | 6.5% | -24.77% | 66.24% | 34/159 | 5% | 哈三联 | 27.17% | 行业排名> |
| 2019-03-31 | 3.91% | 0% | -76.47% | 20/159 | 2.46% | 汇宇制药 | 55.94% | 行业排名> |
| 2018-12-31 | 16.62% | 170.68% | 11.77% | 30/159 | 7.64% | 河化股份 | 45.32% | 行业排名> |
| 2018-09-30 | 14.87% | 78.94% | 72.11% | 13/159 | 7.31% | 汇宇制药 | 31.9% | 行业排名> |
| 2018-06-30 | 8.64% | 260% | 120.97% | 16/159 | 4.68% | 誉衡药业 | 35.56% | 行业排名> |
| 2018-03-31 | 3.91% | 15.68% | -36.32% | 19/159 | 2.65% | 奥赛康 | 35% | 行业排名> |
| 2017-12-31 | 6.14% | 19.46% | -26.11% | 78/159 | 9.67% | 奥赛康 | 28.15% | 行业排名> |
| 2017-09-30 | 8.31% | 43.03% | 246.25% | 44/159 | 8.3% | 宏源药业 | 21.91% | 行业排名> |
| 2017-06-30 | 2.4% | -27.05% | -28.99% | 83/159 | 5.55% | 奥赛康 | 9.7% | 行业排名> |
| 2017-03-31 | 3.38% | 120.92% | -34.24% | 22/159 | 2.12% | 奥赛康 | 40.69% | 行业排名> |
| 2016-12-31 | 5.14% | -18.8% | -11.53% | 87/159 | 7.25% | 信立泰 | 25.93% | 行业排名> |
| 2016-09-30 | 5.81% | -16.64% | 76.6% | 49/159 | 5.66% | 昂利康 | 15.91% | 行业排名> |
| 2016-06-30 | 3.29% | -19.95% | 115.03% | 57/159 | 3.81% | 奥赛康 | 12.08% | 行业排名> |
| 2016-03-31 | 1.53% | -25.37% | -75.83% | 52/159 | 2.57% | 一品红 | 31.62% | 行业排名> |
| 2015-12-31 | 6.33% | 148.24% | -9.18% | 70/159 | 11.33% | 丽珠集团 | 49.43% | 行业排名> |
| 2015-09-30 | 6.97% | 21.43% | 69.59% | 39/159 | 7.09% | 河化股份 | 54.24% | 行业排名> |
| 2015-06-30 | 4.11% | 14.48% | 100.49% | 50/159 | 5.03% | 华东医药 | 7.2% | 行业排名> |
| 2015-03-31 | 2.05% | -9.69% | -19.61% | 39/159 | 2.31% | 南新制药 | 81.7% | 行业排名> |
| 2014-12-31 | 2.55% | -38.55% | -55.57% | 90/159 | 12.08% | 德展健康 | 29.5% | 行业排名> |
| 2014-09-30 | 5.74% | 25.33% | 59.89% | 37/159 | 7.35% | 贝达药业 | 16.78% | 行业排名> |
| 2014-06-30 | 3.59% | 15.43% | 58.15% | 40/159 | -4.53% | 河化股份 | 19.29% | 行业排名> |
| 2014-03-31 | 2.27% | 19.47% | -45.3% | 29/159 | 2.06% | 一品红 | 58.17% | 行业排名> |
| 2013-12-31 | 4.15% | 171.24% | -9.39% | 76/159 | 10.14% | -- | -- | 行业排名> |
| 2013-09-30 | 4.58% | 64.16% | 47.27% | 39/159 | 5.63% | -- | -- | 行业排名> |
| 2013-06-30 | 3.11% | -0.96% | 63.68% | 40/159 | 3.19% | 广生堂 | 15.57% | 行业排名> |
| 2013-03-31 | 1.9% | 5.56% | 24.18% | 29/159 | 1.54% | -- | -- | 行业排名> |